Insomnia as a predictor of treatment outcomes in adolescents receiving concentrated exposure treatment for OCD.


Journal

BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559

Informations de publication

Date de publication:
18 Oct 2024
Historique:
received: 22 11 2023
accepted: 14 10 2024
medline: 19 10 2024
pubmed: 19 10 2024
entrez: 18 10 2024
Statut: epublish

Résumé

Research suggests that individuals with obsessive-compulsive disorder (OCD) frequently experience insomnia. Some previous studies have suggested that insomnia may predict treatment outcomes, but the evidence is limited, especially for adolescents. This study examined the prevalence of insomnia in an adolescent OCD patient sample, explored the correlation between OCD and insomnia, and tested whether levels of insomnia at baseline predict outcomes for adolescent patients receiving the Bergen 4-Day Treatment (B4DT) for OCD. Forty-three adolescent OCD patients who received B4DT were selected for this study. Treatment outcome was quantified as change in Children Yale-Brown Obsessive Compulsive Scale (CY-BOCS) scores across time from pre- to posttreatment and 3-month follow-up. Insomnia symptoms were measured by the Bergen Insomnia Scale (BIS). Linear mixed models were used to examine the relationship between the BIS and changes in CY-BOCS scores. We controlled for symptoms of general anxiety disorder measured by the GAD-7 and depression symptoms measured by the PHQ-9. In this sample, 68.4% of the patients scored above the cutoff for insomnia on the BIS. There was a moderate correlation between baseline CY-BOCS and BIS that did not reach statistical significance (r = .32, p = .051). High BIS scores before treatment were significantly associated with poorer treatment outcomes, as measured by changes in CY-BOCS over time (p = .002). The association between baseline insomnia and change in OCD symptoms remained significant (p = .033) while controlling for GAD-7 and PHQ-9. Insomnia is common among adolescents with OCD, and these data suggest that these patients may be at increased risk for poor treatment outcomes. Future research to explore mechanisms and adjunctive treatments is warranted. The study was approved by the Regional Committee for Medical and Health Research Ethics of Northern Norway (REK Nord: 2023/606482).

Sections du résumé

BACKGROUND BACKGROUND
Research suggests that individuals with obsessive-compulsive disorder (OCD) frequently experience insomnia. Some previous studies have suggested that insomnia may predict treatment outcomes, but the evidence is limited, especially for adolescents. This study examined the prevalence of insomnia in an adolescent OCD patient sample, explored the correlation between OCD and insomnia, and tested whether levels of insomnia at baseline predict outcomes for adolescent patients receiving the Bergen 4-Day Treatment (B4DT) for OCD.
METHODS METHODS
Forty-three adolescent OCD patients who received B4DT were selected for this study. Treatment outcome was quantified as change in Children Yale-Brown Obsessive Compulsive Scale (CY-BOCS) scores across time from pre- to posttreatment and 3-month follow-up. Insomnia symptoms were measured by the Bergen Insomnia Scale (BIS). Linear mixed models were used to examine the relationship between the BIS and changes in CY-BOCS scores. We controlled for symptoms of general anxiety disorder measured by the GAD-7 and depression symptoms measured by the PHQ-9.
RESULTS RESULTS
In this sample, 68.4% of the patients scored above the cutoff for insomnia on the BIS. There was a moderate correlation between baseline CY-BOCS and BIS that did not reach statistical significance (r = .32, p = .051). High BIS scores before treatment were significantly associated with poorer treatment outcomes, as measured by changes in CY-BOCS over time (p = .002). The association between baseline insomnia and change in OCD symptoms remained significant (p = .033) while controlling for GAD-7 and PHQ-9.
CONCLUSION CONCLUSIONS
Insomnia is common among adolescents with OCD, and these data suggest that these patients may be at increased risk for poor treatment outcomes. Future research to explore mechanisms and adjunctive treatments is warranted.
TRIAL REGISTRATION BACKGROUND
The study was approved by the Regional Committee for Medical and Health Research Ethics of Northern Norway (REK Nord: 2023/606482).

Identifiants

pubmed: 39425125
doi: 10.1186/s12888-024-06183-3
pii: 10.1186/s12888-024-06183-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

702

Informations de copyright

© 2024. The Author(s).

Références

Ruscio AM, Stein DJ, Chiu WT, Kessler RC. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry. 2010;15(1):53–63.
doi: 10.1038/mp.2008.94 pubmed: 18725912
Anholt G, Aderka I, Balkom AV, Smit J, Schruers K, Van der Wee N, et al. Age of onset in obsessive–compulsive disorder: admixture analysis with a large sample. Psychol Med. 2014;44(1):185–94.
doi: 10.1017/S0033291713000470 pubmed: 23517651
Nelson E, Rice J. Stability of diagnosis of obsessive compulsive disorder in the epidemiologic catchment area study. Am J Psychiatry. 1997;154:826–31.
doi: 10.1176/ajp.154.6.826 pubmed: 9167511
Melkonian M, McDonald S, Scott A, Karin E, Dear BF, Wootton BM. Symptom improvement and remission in untreated adults seeking treatment for obsessive-compulsive disorder: a systematic review and meta-analysis. J Affect Disord. 2022;318:175–84.
doi: 10.1016/j.jad.2022.08.037 pubmed: 36030999
Öst L-G, Riise EN, Wergeland GJ, Hansen B, Kvale G. Cognitive behavioral and pharmacological treatments of OCD in children: a systematic review and meta-analysis. J Anxiety Disord. 2016;43:58–69.
doi: 10.1016/j.janxdis.2016.08.003 pubmed: 27632568
Reid JE, Laws KR, Drummond L, Vismara M, Grancini B, Mpavaenda D et al. Cognitive behavioural therapy with exposure and response prevention in the treatment of obsessive-compulsive disorder: a systematic review and meta-analysis of randomised controlled trials. Compr Psychiatr. 2021;106(152223).
Öst L-G, Ollendick TH. Brief, intensive and concentrated cognitive behavioral treatments for anxiety disorders in children: a systematic review and meta-analysis. Behav Res Ther. 2017;97:134–45.
doi: 10.1016/j.brat.2017.07.008 pubmed: 28772195
Launes G, Hagen K, Sunde T, Öst L-G, Klovning I, Laukvik IL et al. A Randomized Controlled Trial of Concentrated ERP, Self-Help and Waiting List for obsessive- compulsive disorder: the Bergen 4-Day treatment. Front Psychol. 2019;10(1069).
Havnen A, Hansen B, Öst L-G, Kvale G. Concentrated ERP delivered in a group setting: an effectiveness study. J Obsessive-Compulsive Relat Disorders. 2014;3(4):319–24.
doi: 10.1016/j.jocrd.2014.08.002
Hansen B, Kvale G, Hagen K, Havnen A, Öst L-G. The Bergen 4-day treatment for OCD: four years follow-up of concentrated ERP in a clinical mental health setting. Cogn Behav Ther. 2019(2):89–105.
Riise EN, Kvale G, L-G Ö, Skjold SH, Hansen H, Hansen B. Concentrated exposure and response prevention for adolescents with obsessive-compulsive disorder: an effectiveness study. J Obsessive-Compulsive Relat Disorders. 2016;11:13–21.
doi: 10.1016/j.jocrd.2016.07.004
Riise EN, Kvale G, Öst L-G, Skjold SH, Hansen B. Concentrated exposure and response prevention for adolescents with obsessive-compulsive disorder: a replication study. J Obsessive-Compulsive Relat Disorders. 2018;19:15–22.
doi: 10.1016/j.jocrd.2018.07.002
Herzog P, Osen B, Stierle C, Middendorf T, Voderholzer U, Koch S, et al. Determining prognostic variables of treatment outcome in obsessive-compulsive disorder: effectiveness and its predictors in routine clinical care. Eur Arch Psychiatry Clin Neurosci. 2022;272(2):313–26.
doi: 10.1007/s00406-021-01284-6 pubmed: 34218306
Torp NC, Dahl K, Skarphedinsson G, Compton S, Thomsen PH, Weidle B et al. Predictors Associated with improved cognitive-behavioral therapy outcome in Pediatric Obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 2015;54(3).
Kathmann N, Jacobi T, Elsner B, Reuter B. Effectiveness of individual cognitive-behavioral therapy and predictors of outcome in adult patients with obsessive-compulsive disorder. Psychiatry Psychol. 2022;91(2):123–35.
Ivarsson T., Skarphedinsson, G. Sleep problems and cognitive behavior therapy in pediatric obsessive-compulsive disorder have bidirectional effects. J Anxiety Disord. 2015;30:28–33.
doi: 10.1016/j.janxdis.2014.12.009 pubmed: 25591044
Gajadien PT, Postma TS, Oostrom Iv, Scheepstra KWF, Dijk Hv, Sack AT et al. Sleep predicts the response to rTMS and CBT in patients with OCD: an open label effectiveness study International. J Clin Health Psychol. 2023;23(2).
Nordahl H, Havnen A, Hansen B, Öst L-G, Kvale G. Sleep disturbances in treatment-seeking OCD-patients: changes after concentrated exposure treatment. Scand J Psychol. 2018;59(2):186–91.
doi: 10.1111/sjop.12417 pubmed: 29244201
Hagen K, Nordahl H, Launes G, Kvale G, Öst L-G, Hystad S et al. Does concentrated exposure treatment for obsessive-compulsive disorder improve insomnia symptoms? Results from a Randomized Controlled Trial. Front Psychiatry. 2021;12.
Buysse DJ, Insomnia. JAMA. 2013;309(7):706–16.
doi: 10.1001/jama.2013.193 pubmed: 23423416 pmcid: 3632369
Sateia MJ. International classification of sleep disorders-third edition: highlights and modifications. Chest. 2014;146(5):1387–94.
doi: 10.1378/chest.14-0970 pubmed: 25367475
Massar SAA, Lim J, Sasmita K, Chee MWL. Sleep deprivation increases the costs of attentional effort: performance, preference and pupil size. Neuropsychologia. 2019;123:169–77.
doi: 10.1016/j.neuropsychologia.2018.03.032 pubmed: 29601889
Axelsson EL, Williams SE, Horst JS. The Effect of Sleep on Children’s Word Retention and Generalization. Front Psychol. 2016;7.
Seo J, Moore KN, Gazecki S, Bottary RM, Milad MR, Song H et al. Delayed fear extinction in individuals with insomnia disorder. Sleep. 2018;41(8).
Cox RC, Olatunji BO. Linking insomnia and OCD symptoms during the coronavirus pandemic: examination of prospective associations. J Anxiety Disord. 2021;77(102341).
Segal SC, Carmona NE. A systematic review of sleep problems in children and adolescents with obsessive compulsive disorder. J Anxiety Disord. 2022;90.
Reynolds KC, Gradisar M, Alfano CA. Sleep in children and adolescents with obesessive-compulsive disorder. Sleep Med Clin. 2015;10(2):133–41.
doi: 10.1016/j.jsmc.2015.02.006 pubmed: 26055861
Cox RC, Olatunji BO. Delayed circadian rhythms and insomnia symptoms in obsessive-compulsive disorder. J Affect Disord. 2022;318:94–102.
doi: 10.1016/j.jad.2022.08.118 pubmed: 36057288 pmcid: 10201922
Hellberg SN, Buchholz JL, Abramowitz JS. Insomnia and obsessive-compulsive symptom dimensions: the mediating role of anxiety and depression. J Obsessive-Compulsive Relat Disorders. 2019;23.
Sevilla-Cermeño L, Isomura K, Larsson H, Åkerstedt T, Vilaplana-Pérez A, Lahera G, et al. Insomnia in obsessive-compulsive disorder: a Swedish population-based cohort study. J Affect Disord. 2020;266:413–6.
doi: 10.1016/j.jad.2020.01.122 pubmed: 32056907
Hysing M, Pallesen S, Stormark KM, Lundervold AJ, Sivertsen B. Sleep patterns and insomnia among adolescents: a population-based study. J Sleep Res. 2013;22(5):549–56.
doi: 10.1111/jsr.12055 pubmed: 23611716
Baglioni C, Nanovska S, Regen W, Spiegelhalder K, Feige B, Nissen C, et al. Sleep and mental disorders: a meta-analysis of polysomnographic research. Psychol Bull. 2016;142(9):969–90.
doi: 10.1037/bul0000053 pubmed: 27416139 pmcid: 5110386
Ivarsson T, Larsson B. Sleep problems as reported by parents in Swedish children and adolescents with obsessive-compulsive disorder (OCD), child psychiatric outpatients and school children. Nord J Psychiatry. 2009;63:480–4.
doi: 10.3109/08039480903075200 pubmed: 19958257
Skjold SH, Hagen K, Wheaton MG, Hjelle KM, Björgvinsson T, Hansen B. The effectiveness and acceptability of the Bergen 4-Day treatment for adolescents suffering from OCD. A replication and extension. BMC Psychiatry. 2024;24(1).
Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, et al. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36(7):980–8.
doi: 10.1097/00004583-199707000-00021 pubmed: 9204677
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(20):22–33.
pubmed: 9881538
Scahill L, Riddle MA, McSwiggin-Hardin M, Ort SI, King RA, Goodman WK, et al. Children’s Yale-Brown Obsessive compulsive scale: reliability and validity. J Am Acad Child Adolesc Psychiatry. 1997;36(6):844–52.
doi: 10.1097/00004583-199706000-00023 pubmed: 9183141
Pallesen S, Bjorvatn B, Nordhus IH, Sivertsen B, Hjornevik M, Morin CM. A new scale for measuring insomnia: the Bergen Insomnia Scale. Percept Mot Skills. 2008;107:3.
doi: 10.2466/pms.107.3.691-706
Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatric Annals. 2002;32(9):509–15.
doi: 10.3928/0048-5713-20020901-06
Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.
doi: 10.1001/archinte.166.10.1092
Engle-Friedman M. The effects of sleep loss on capacity and effort. Sleep Sci. 2014;7(4):213–24.
doi: 10.1016/j.slsci.2014.11.001 pubmed: 26483932 pmcid: 4608917
Nota AJ, Sharkey KM, Coles ME. Sleep, arousal, and circadian rhythms in adults with obsessive–compulsive disorder: a meta-analysis. Neurosci Biobehavioral Reviews. 2015;51:100–7.
doi: 10.1016/j.neubiorev.2015.01.002
Crowley CJ, Acebo C, Carskadon MA. Sleep, circadian rhythms, and delayed phase in adolescence. Sleep Med. 2007;8(6):602–12.
doi: 10.1016/j.sleep.2006.12.002 pubmed: 17383934

Auteurs

Solvei Harila Skjold (SH)

Bergen Center for Brain Plasticity, Haukeland University Hospital, Bergen, Norway. soskj2127@uib.no.
Center for Crisis Psychology, Faculty of Psychology, University of Bergen, Bergen, Norway. soskj2127@uib.no.
Haukeland University Hospital, OCD-team, Bergen, Norway. soskj2127@uib.no.

Kristen Hagen (K)

Bergen Center for Brain Plasticity, Haukeland University Hospital, Bergen, Norway.
Møre and Romsdal Hospital Trust, Molde, Norway.

Michael G Wheaton (MG)

Barnard College, Columbia University, New York, USA.
Center for OCD and Related Disorders, Massachusetts General Hospital, Boston, USA.

Håvard Kallestad (H)

NTNU, Trondheim, Norway.

Kay Morten Hjelle (KM)

Bergen Center for Brain Plasticity, Haukeland University Hospital, Bergen, Norway.
Center for Crisis Psychology, Faculty of Psychology, University of Bergen, Bergen, Norway.

Thröstur Björgvinsson (T)

Harvard Medical School, Boston, USA.
McLean Hospital, Belmont, USA.

Bjarne Hansen (B)

Bergen Center for Brain Plasticity, Haukeland University Hospital, Bergen, Norway.
Center for Crisis Psychology, Faculty of Psychology, University of Bergen, Bergen, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH